Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Prehabilitation With Aerobic and Resistance Exercise for Improving Physical Fitness and Quality of Life Outcomes in Older Patients Undergoing CAR-T Therapy for Relapsed or Refractory Multiple Myeloma [NA]
This clinical trial assesses whether a prehabilitation program combining aerobic and resistance exercise improves physical fitness and quali…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Questionnaire and Tissue Banking For Multiple Myeloma, Waldenstrom Macroglobulinemia and Related Disorders
A clinical trial registry update from Dana-Farber Cancer Institute notes a study involving questionnaires and tissue banking for multiple my…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 clinical trial update assessing the safety (adverse events) and preliminary activity of ABBV-383 given by subcutaneous injection i…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma [Phase 3]
Phase 3 trial evaluating Anitocabtagene Autoleucel versus standard of care in relapsed/refractory multiple myeloma; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma
A clinical trial is evaluating Epunamin in combination with the DECP regimen for relapsed/refractory multiple myeloma, currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments [Phase 3]
Clinical trial update announcing a Phase 3 study of elranatamab alone and with daratumumab for multiple myeloma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) [Phase 2]
The CAPTUR Phase 2 trial by the Canadian Cancer Trials Group is currently recruiting and evaluates profiling and targeted agent utilization …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant [Phase 3]
Phase 3 clinical trial comparing linvoseltamab to standard treatment in adults with multiple myeloma who are not transplant-eligible to eval…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation [Phase 3]
A Phase 3 clinical trial is evaluating teclistamab with lenalidomide and teclistamab alone versus lenalidomide alone as maintenance therapy …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers [NA]
A clinical trial is recruiting to test an AI-generated, personalized question prompt list designed to help patients with lymphoma or multipl…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: A Study of GR1803 Injection Versus Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Participants With Relapsed or Refractory Multiple Myeloma [Phase 3]
This Phase 3 trial compares GR1803 Injection against the DPd regimen (daratumumab, pomalidomide, and dexamethasone) in relapsed or refractor…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is currently recruiting to evaluate a combination of two approved drugs with one experimental drug in patients wi…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma [Phase 2]
Clinical trial update for a Phase 2 study evaluating a quadruplet regimen of daratumumab, carfilzomib, lenalidomide, and dexamethasone in ne…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction [Phase 2]
Phase 2 trial evaluating PD-1Ab21-BCMA CAR-T therapy as consolidation for multiple myeloma with renal dysfunction; the study is currently re…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) [Phase 3]
A Phase 3 trial comparing mezigdomide, bortezomib and dexamethasone (MEZVd) versus pomalidomide, bortezomib and dexamethasone (PVd) in relap…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: A Phase I Study of SHR-3836 in Patients With Multiple Myeloma [Phase 1]
A Phase I clinical trial of SHR-3836 for multiple myeloma is listed as not yet recruiting. The sponsor is Shanghai Hengrui Pharmaceutical Co…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma [Phase 1]
A phase 1 clinical trial update evaluating selinexor as maintenance therapy after CAR-T cell therapy in multiple myeloma, currently recruiti…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Study of Carfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma [Phase 1, Phase 2]
Clinical trial update for a Phase 1/2 study of a four-drug combination (carfilzomib, lenalidomide, vorinostat, and dexamethasone) in relapse…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases
Pfizer-sponsored observational study in Italian hematology centers aims to understand how patients with triple class refractory multiple mye…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
This document announces an ongoing registry and sample resource at Ohio State University Comprehensive Cancer Center for plasma cell dyscras…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma [Phase 1, Phase 2]
Phase 1/2 trial evaluating a combination of selinexor, carfilzomib, isatuximab, and dexamethasone in relapsed or refractory multiple myeloma…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial [Phase 3]
This entry details a Phase 3 extension study of Venetoclax for patients who completed prior Venetoclax trials. The study is currently active…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Multiple Myeloma Extramedulary Disease Samples FFPE
BIWAKO-sponsored clinical trial evaluating extramedullary disease samples from multiple myeloma patients. The study is currently not yet rec…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing [Phase 2]
This Phase 2 clinical trial update aims to identify an effective and cost-conscious maintenance dosing regimen for daratumumab in patients w…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Impact of Budesonide on Incidence of ≥ Gr2 Diarrhea in Multiple Myeloma (MM) Patients Undergoing Autologous Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating whether budesonide reduces the incidence of grade 2 or higher diarrhea in multiple myeloma patients underg…